Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow  0.00% Nasdaq Up 0.52%
Streaming
Ticker Tape: On

More On OXB.L

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Oxford BioMedica PLC (OXB.L)

-LSE
2.18 Down 0.02(0.91%) Apr 24
Get the big picture on all your investments.
Prev Close:2.17
Open:2.17
Bid:1.95
Ask:2.25
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:2.12 - 2.19
52wk Range:1.30 - 3.80
Volume:416,956
Avg Vol (3m):891,319
Market Cap:30.87M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):571.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.33
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oxford BioMedica plc, a biopharmaceutical company, develops gene-based medicines and therapeutic vaccines for the treatment of cancer, and age-related or inherited neurodegenerative disorders and ocular diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback